Jul 15, 2022 4:05 pm EDT NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
Jun 21, 2022 2:00 am EDT NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
Jun 3, 2022 4:05 pm EDT NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
Jun 3, 2022 7:00 am EDT NeoGenomics Receives CAP Certification in their Suzhou China Pharma Services Laboratory
May 10, 2022 2:00 am EDT NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR(R) MRD and InVisionFirst(R)-Lung Tests at the 2022 ASCO Annual Meeting
May 9, 2022 7:00 am EDT NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
Apr 25, 2022 7:00 am EDT NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay
